Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Taiko Pharmaceutical Co., Ltd. ( (JP:4574) ) has provided an update.
Taiko Pharmaceutical Co., Ltd. has completed the liquidation of its subsidiary, Taiko Environmental Technologies (Shanghai) Co., Ltd., resulting in a special gain of 142 million yen. This liquidation and subsequent gain have led the company to revise its consolidated earnings forecast for the fiscal year ending December 2025, increasing the profit attributable to owners of the parent by 50% compared to the previous forecast.
More about Taiko Pharmaceutical Co., Ltd.
Taiko Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on infection control products. The company is listed on the Tokyo Stock Exchange Prime and is known for its commitment to health and wellness solutions.
Average Trading Volume: 701,004
Technical Sentiment Signal: Sell
Current Market Cap: Yen14.87B
Learn more about 4574 stock on TipRanks’ Stock Analysis page.